Position in KURA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,833,627
-$473,012 QoQ
Shares Held
1,169,884
-28.5% QoQ
Ownership
1.32%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#17
of 220 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. KURA ranks #40 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in KURA
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,833,627 | 1,169,884 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $13,306,639 | 1,636,733 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,855,303 | 1,333,523 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $15,157,536 | 1,712,716 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,031,582 | 1,911,886 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,742,625 | 1,173,125 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,718,104 | 1,115,741 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,013,968 | 103,069 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $758,238 | 35,548 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,278,223 | 88,889 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | $456,146 | 43,114 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $234,387 | 18,887 | Shares | Sole | 2023-02-14 | |
| 2021-06-30 | $1,153,150 | 55,307 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $333,642 | 11,802 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $229,861 | 7,038 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||